Ryuta Uraki, Maki Kiso, Kiyoko Iwatsuki-Horimoto, Seiya Yamayoshi, Mutsumi Ito, Shiho Chiba, Yuko Sakai-Tagawa, Masaki Imai, Yukie Kashima, Michiko Koga, et al. Characterization of a SARS-CoV-2 EG.5.1 clinical isolate in vitro and in vivo. Cell reports. 2023. 42. 12. 113580-113580
Hideaki Kato, Takayuki Kurosawa, Kazuo Horikawa, Yayoi Kimura, Kei Miyakawa, Akihide Ryo, Atsushi Goto. Humoral response against spike protein enhanced by fifth and sixth COVID-19 mRNA vaccine in the uninfected and infected subjects. Human vaccines & immunotherapeutics. 2023. 19. 3. 2278376-2278376
Takeshi Arashiro, Maki Miwa, Hidenori Nakagawa, Junpei Takamatsu, Kunihiro Oba, Satoshi Fujimi, Hitoshi Kikuchi, Takamasa Iwasawa, Fumiko Kanbe, Keisuke Oyama, et al. COVID-19 vaccine effectiveness against severe COVID-19 requiring oxygen therapy, invasive mechanical ventilation, and death in Japan: A multicenter case-control study (MOTIVATE study). Vaccine. 2023
Takeshi Arashiro, Yuzo Arima, Jin Kuramochi, Hirokazu Muraoka, Akihiro Sato, Kumi Chubachi, Kunihiro Oba, Atsushi Yanai, Hiroko Arioka, Yuki Uehara, et al. Immune escape and waning immunity of COVID-19 monovalent mRNA vaccines against symptomatic infection with BA.1/BA.2 and BA.5 in Japan. Vaccine. 2023
Kayoko Hayakawa, Yasufumi Matsumura, Kohei Uemura, Shinya Tsuzuki, Aki Sakurai, Ryutaro Tanizaki, Koh Shinohara, Takehiro Hashimoto, Ryota Hase, Takashi Matono, et al. Effectiveness of cefmetazole versus meropenem for invasive urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli. Antimicrobial agents and chemotherapy. 2023. 67. 10. e0051023